Found 4419 matching trials
Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy PHASE2 The trial is designed as a multi-center, open label Phase 2 trial that inve...
Show More Location
3203; Antwerp University Hospital; Department of Medical Oncology
Learn More & Join Trial
A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas PHASE1 This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Show More Location
Multiple Locations
Learn More & Join Trial
Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia PHASE2 Prospective, double-blind, randomized assessment of the efficacy, safety an...
Show More Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer PHASE2 The objective of this study is to assess the efficacy, safety of MRG003 as ...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
A Clinical Study of MIL95 in Advanced Malignancies. PHASE1 This study is composed of two stages: Part A initial dose escalation and Pa...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Bela 8 Week Dosing PHASE4 The purpose of this study is to transition patients who have been stable on...
Show More Learn More & Join Trial
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis PHASE2 Leptomeningeal metastasis (LM) is a devastating and terminal complication o...
Show More Location
Multiple Locations
Learn More & Join Trial
Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer PHASE2 For patients with metastatic gastric cancer, the efficacy of current standa...
Show More Location
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
JSKN003 Combined Treatment of HER2-positive Gastric Cancer PHASE2 This study is designed to evaluate the safety and efficacy of JSKN003 combi...
Show More Location
Multiple Locations
Learn More & Join Trial
Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04) PHASE3 This study will evaluate the efficacy and safety of trastuzumab deruxtecan ...
Show More Status
Active Not Recruiting
Location
Instituto Medico Especializado Alexander Fleming
Learn More & Join Trial